Bernstein Keeps a Buy on Agilon Health (AGL) With a Price Target of $7.50

Agilon Health, Inc. (NYSE:AGL) is one of the 13 Stocks Under $5 With High Upside Potential. In a report released on June 17, Lance Wilkes from Bernstein maintained a Buy rating on Agilon Health, Inc. (NYSE:AGL) with a price target of $7.50.

Why Agilon Health Inc (AGL) is Surging in 2025

A doctor in scrubs interacting with a Medicare Advantage member in her home.

The company reported $1.53 billion in total revenues in fiscal Q1 2025, with Medicare Advantage membership of 491,000, and 605,000 total members on the Agilon platform. Management expressed optimism about the company’s strategic long-term growth priorities, supported by investments in clinical programs and technology to drive increased shareholder value.

Agilon Health, Inc. (NYSE:AGL) provides healthcare services and also engages in the provision of technology, capital, people, process, and access to a peer network of primary care physicians.

While we acknowledge the potential of AGL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.